Fundraising September 15, 2024 – October 1, 2024 About fundraising

Volume 79; Issue 4

Clinical Pharmacology & Therapeutics

Volume 79; Issue 4

1

Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements

AQUILANTE, C, LANGAEE, T, LOPEZ, L, YARANDI, H, TROMBERG, J, MOHUCZY, D, GASTON, K, WADDELL, C, CHIRICO, M, JOHNSON, J

Journal:

Clinical Pharmacology & Therapeutics

Year:

2006

Language:

english

File:

PDF, 150 KB

english, 2006

2

MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotype

LAMBA, J, STROM, S, VENKATARAMANAN, R, THUMMEL, K, LIN, Y, LIU, W, CHENG, C, LAMBA, V, WATKINS, P, SCHUETZ, E

Journal:

Clinical Pharmacology & Therapeutics

Year:

2006

Language:

english

File:

PDF, 1.08 MB

english, 2006

3

Identification and characterization of CYP3A4*20, a novel rare CYP3A4 allele without functional activity

WESTLINDJOHNSSON, A, HERMANN, R, HUENNEMEYER, A, HAUNS, B, LAHU, G, NASSR, N, ZECH, K, INGELMANSUNDBERG, M, VONRICHTER, O

Journal:

Clinical Pharmacology & Therapeutics

Year:

2006

Language:

english

File:

PDF, 496 KB

english, 2006

4

Comparison of midazolam and simvastatin as cytochrome P450 3A probes

CHUNG, E, NAFZIGER, A, KAZIERAD, D, BERTINOJR, J

Journal:

Clinical Pharmacology & Therapeutics

Year:

2006

Language:

english

File:

PDF, 225 KB

english, 2006

5

Severe arrhythmia as a result of the interaction of cetirizine and pilsicainide in a patient with renal insufficiency: First case presentation showing competition for excretion via renal multidrug resistance protein 1 and organic cation transporter 2

TSURUOKA, S, IOKA, T, WAKAUMI, M, SAKAMOTO, K, OOKAMI, H, FUJIMURA, A

Journal:

Clinical Pharmacology & Therapeutics

Year:

2006

Language:

english

File:

PDF, 253 KB

english, 2006

6

A therapeutic substitution policy for proton pump inhibitors: Clinical and economic consequences

SCHNEEWEISS, S, MACLURE, M, DORMUTH, C, GLYNN, R, CANNING, C, AVORN, J

Journal:

Clinical Pharmacology & Therapeutics

Year:

2006

Language:

english

File:

PDF, 362 KB

english, 2006

7

Effect of voriconazole on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam

SAARI, T, LAINE, K, LEINO, K, VALTONEN, M, NEUVONEN, P, OLKKOLA, K

Journal:

Clinical Pharmacology & Therapeutics

Year:

2006

Language:

english

File:

PDF, 340 KB

english, 2006

8

Rofecoxib regulates the expression of genes related to the matrix metalloproteinase pathway in humans: Implication for the adverse effects of cyclooxygenase-2 inhibitors

WANG, X, WU, T, LEE, Y, DIONNE, R

Journal:

Clinical Pharmacology & Therapeutics

Year:

2006

Language:

english

File:

PDF, 514 KB

english, 2006

9

Analgesic effect of acetaminophen in humans: First evidence of a central serotonergic mechanism

PICKERING, G, LORIOT, M, LIBERT, F, ESCHALIER, A, BEAUNE, P, DUBRAY, C

Journal:

Clinical Pharmacology & Therapeutics

Year:

2006

Language:

english

File:

PDF, 280 KB

english, 2006

10

Correction

Journal:

Clinical Pharmacology & Therapeutics

Year:

2006

Language:

english

File:

PDF, 41 KB

english, 2006

11

A message from the ASCPT Membership Committee Chairperson

Journal:

Clinical Pharmacology & Therapeutics

Year:

2006

Language:

english

File:

PDF, 30 KB

english, 2006

12

Environmental and genetic factors associated with morphine response in the postoperative period

COULBAULT, L, BEAUSSIER, M, VERSTUYFT, C, WEICKMANS, H, DUBERT, L, TREGOUET, D, DESCOT, C, PARC, Y, LIENHART, A, JAILLON, P

Journal:

Clinical Pharmacology & Therapeutics

Year:

2006

Language:

english

File:

PDF, 123 KB

english, 2006

13

Welcome new ASCPT Members

Journal:

Clinical Pharmacology & Therapeutics

Year:

2006

Language:

english

File:

PDF, 48 KB

english, 2006

14

Correction

Journal:

Clinical Pharmacology & Therapeutics

Year:

2006

Language:

english

File:

PDF, 43 KB

english, 2006